Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Am J Sports Med. 2016 Feb 12;44(11):2993–3005. doi: 10.1177/0363546515624673

TABLE 1.

Levels of Evidence and PEDro Scores for All Included Studiesa

Study Level of Evidence PEDro Scale Itemsb
Total Score
1 2 3 4 5 6 7 8 9 10 11
Astur et al1 1b 1 1 1 1 0 0 0 1 0 1 1 6
Csintalan et al11 4 1 0 0 0 0 0 0 1 0 0 1 2
Deie et al12 4 1 0 0 0 0 0 0 1 0 1 1 3
Ellera Gomes15 4 1 0 0 1 0 0 0 1 0 1 1 4
Feller et al17 4 1 0 0 0 0 0 0 1 0 1 1 3
Fink et al18 4 1 0 0 1 0 0 0 1 0 1 1 4
Goyal22 4 1 0 0 0 0 0 0 1 0 1 1 3
Kang et al27 4 1 0 0 0 0 0 0 1 0 0 1 2
Matthews and Schranz34 1b 1 0 0 0 0 0 0 1 0 1 1 3
Mulliez et al40 4 1 0 0 0 0 0 0 1 0 0 0 1
Panagopoulos et al45 4 1 0 0 0 0 0 0 1 0 1 1 3
Panni et al46 4 0 0 0 0 0 0 0 1 0 1 1 3
Wagner et al71 4 1 0 0 0 0 0 0 1 0 1 1 3
Witonski et al73 4 1 0 0 0 0 0 0 0 0 1 1 2
a

The Physiotherapy Evidence Database (PEDro) scale is optimal for evaluating randomized controlled trials; therefore, it should be interpreted with caution in the studies included here, as they are nonrandomized. PEDro criterion 1 is not counted toward the total score according to the Physiotherapy Evidence Database guidelines.

b

Scale items: 1 = eligibility criteria specified; 2 = random allocation of participants; 3 = allocation concealed; 4 = similar groups at baseline; 5 = blinding of participants; 6 = blinding of intervention providers; 7 = blinding of outcome assessors; 8 = outcomes obtained from 85% of participants; 9 = use of intent-to-treat analysis if protocol violated; 10 = between-group statistical comparison; and 11 = point measures and measures of variability. “1” indicates a “yes” score, and “0” indicates a “no” score.